Ajanta Pharma Limited has informed the Exchange about Schedule of meet
AJANTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Ajanta Pharma has announced an Earnings Conference Call scheduled for May 5, 2026 at 16:30 hrs IST. The call will follow the release of Q4 FY 2026 Audited Financial Results after the Board meeting. During the 1-hour call, the company's leadership team will discuss financial performance and answer investor questions. International dial-in numbers are provided for investors in USA, UK, Hong Kong, and Singapore. A transcript and audio playback will be available on the company website after the call.
This is a routine earnings announcement. The scheduled conference call provides shareholders an opportunity to hear management discuss Q4 FY 2026 results and ask questions directly. No immediate impact on stock price expected from this filing alone.